Post-COVID-19 co-morbidity of emerged Lophomonas infection and invasive pulmonary aspergillosis: First case report.

Ali SharifpourZakaria Zakariaei Mahdi FakharElham Sadat BanimostafaviMaryam NakhaeiMostafa Soleymani

Published in: Clinical case reports (2021)

Due to long corticosteroid therapy in patients with COVID-19, in case of cough, dyspnea, and weight loss, emerging pulmonary aspergillosis and lophomoniasis should be ruled out.

Keyphrases

case report
weight loss
pulmonary hypertension
coronavirus disease
sars cov
bariatric surgery
roux en y gastric bypass
gastric bypass
bone marrow
respiratory syndrome coronavirus
skeletal muscle
cell therapy
insulin resistance
smoking cessation